HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)
Open Access
- 20 January 2009
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 100 (3), 470-475
- https://doi.org/10.1038/sj.bjc.6604857
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- c-Fos as a Proapoptotic Agent in TRAIL-Induced Apoptosis in Prostate Cancer CellsCancer Research, 2007
- Hox genes in time and space during vertebrate body formationDevelopment, Growth & Differentiation, 2007
- Expression of Hoxa2 in rhombomere 4 is regulated by a conserved cross-regulatory mechanism dependent upon Hoxb1Developmental Biology, 2007
- A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cellsCell Death & Differentiation, 2006
- Sustained Expression of Early Growth Response Protein-1 Blocks Angiogenesis and Tumor GrowthCancer Research, 2006
- Hox cofactors in vertebrate developmentDevelopmental Biology, 2006
- EGR1 Predicts PTEN and Survival in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cellsBiochemical Journal, 2003
- Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2Cell Death & Differentiation, 2001
- Amplification and expression of the c-myc oncogene in human lung cancer cell linesNature, 1983